Search
Bioventus Inc
BVSAdd to Watchlist
10.500USD
-0.110-1.04%
Market hours （ET）Quotes delayed by 15 min
710.19MMarket Cap
24.57P/E TTM
More Details of Bioventus Inc Company
Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.
Bioventus Inc Info
Ticker SymbolBVS
Company nameBioventus Inc
IPO dateFeb 11, 2021
CEOClaypoole (Robert E)
Number of employees930
Security typeOrdinary Share
Fiscal year-endFeb 11
Address4721 Emperor Boulevard, Suite 100
CityDURHAM
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code27703
Phone19194746700
Websitehttps://www.bioventus.com/
Ticker SymbolBVS
IPO dateFeb 11, 2021
CEOClaypoole (Robert E)
Company Executives of Bioventus Inc
Name
Name/Position
Position
Shareholding
Change
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
105.96K
--
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
85.24K
--
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
79.62K
--
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
76.44K
--
Mr. Anthony D'adamio, J.D.
Mr. Anthony D'adamio, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
--
--
Ms. Katrina Church, J.D.
Ms. Katrina Church, J.D.
Senior Vice President, Chief Compliance Officer
Senior Vice President, Chief Compliance Officer
--
--
Mr. William A. (Bill) Hawkins, III
Mr. William A. (Bill) Hawkins, III
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Philip G. Cowdy
Mr. Philip G. Cowdy
Independent Director
Independent Director
--
-100.00%
Mr. Guy Paul Nohra
Mr. Guy Paul Nohra
Independent Director
Independent Director
--
--
Marty Sutter ,
Marty Sutter ,
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
105.96K
--
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
85.24K
--
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
79.62K
--
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
76.44K
--
Mr. Anthony D'adamio, J.D.
Mr. Anthony D'adamio, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
--
--
Ms. Katrina Church, J.D.
Ms. Katrina Church, J.D.
Senior Vice President, Chief Compliance Officer
Senior Vice President, Chief Compliance Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Pain Treatments
279.06M
49.12%
Surgical solutions
203.65M
35.85%
Restorative Therapies
85.37M
15.03%
By RegionUSD
Name
Revenue
Proportion
United States
502.10M
88.38%
International
65.99M
11.62%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Pain Treatments
279.06M
49.12%
Surgical solutions
203.65M
35.85%
Restorative Therapies
85.37M
15.03%
Shareholding Stats
Updated: Wed, May 13
Updated: Wed, May 13
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
EW Healthcare Partners
19.22%
Juniper Investment Company, LLC
10.24%
Smith & Nephew Group plc
9.20%
Nantahala Capital Management, LLC
8.93%
BlackRock Institutional Trust Company, N.A.
4.21%
Other
48.21%
Shareholders
Shareholders
Proportion
EW Healthcare Partners
19.22%
Juniper Investment Company, LLC
10.24%
Smith & Nephew Group plc
9.20%
Nantahala Capital Management, LLC
8.93%
BlackRock Institutional Trust Company, N.A.
4.21%
Other
48.21%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
24.27%
Venture Capital
19.29%
Investment Advisor
16.72%
Hedge Fund
15.23%
Corporation
9.20%
Individual Investor
2.15%
Research Firm
1.94%
Bank and Trust
0.40%
Pension Fund
0.27%
Other
10.55%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
339
52.51M
77.51%
-10.20M
2025Q4
319
49.87M
91.76%
-1.55K
2025Q3
324
49.87M
92.42%
+451.64K
2025Q2
315
49.43M
88.24%
+1.39M
2025Q1
300
47.59M
85.68%
-9.15M
2024Q4
302
46.29M
87.45%
+580.76K
2024Q3
303
45.64M
84.02%
-1.26M
2024Q2
271
47.35M
78.83%
+4.38M
2024Q1
269
42.96M
79.86%
-7.88M
2023Q4
267
41.98M
81.20%
+236.50K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
EW Healthcare Partners
13.02M
19.33%
--
--
Dec 31, 2025
Juniper Investment Company, LLC
6.94M
10.3%
--
--
Dec 31, 2025
Smith & Nephew Group plc
6.23M
9.25%
--
--
Apr 07, 2025
Nantahala Capital Management, LLC
6.05M
8.98%
+236.74K
+4.07%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
2.85M
4.23%
+40.52K
+1.44%
Dec 31, 2025
Royce Investment Partners
1.25M
1.86%
-11.69K
-0.93%
Dec 31, 2025
Geode Capital Management, L.L.C.
1.12M
1.66%
+19.39K
+1.76%
Dec 31, 2025
Kent Lake PR LLC
1.00M
1.48%
+650.16K
+185.74%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Vanguard US Multifactor ETF
0.1%
VictoryShares Small Cap Free Cash Flow ETF
0.1%
Harbor Human Capital Factor US Small Cap ETF
0.09%
Fidelity Enhanced Small Cap ETF
0.09%
iShares Micro-Cap ETF
0.06%
Principal U.S. Small-Cap ETF
0.05%
Vanguard US Value Factor ETF
0.04%
Humankind US Stock ETF
0.03%
WisdomTree US SmallCap Fund
0.03%
Avantis US Small Cap Value ETF
0.03%
View more
Vanguard US Multifactor ETF
Proportion0.1%
VictoryShares Small Cap Free Cash Flow ETF
Proportion0.1%
Harbor Human Capital Factor US Small Cap ETF
Proportion0.09%
Fidelity Enhanced Small Cap ETF
Proportion0.09%
iShares Micro-Cap ETF
Proportion0.06%
Principal U.S. Small-Cap ETF
Proportion0.05%
Vanguard US Value Factor ETF
Proportion0.04%
Humankind US Stock ETF
Proportion0.03%
WisdomTree US SmallCap Fund
Proportion0.03%
Avantis US Small Cap Value ETF
Proportion0.03%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
